Safety, Tolerability, and Immunogenicity of COVID-19 Bivalent Vaccination
Vaccines (Basel)
.
2023 May 30;11(6):1040.
doi: 10.3390/vaccines11061040.
Authors
Divyasha Saxena
1
,
Lalit Batra
1
,
Shailendra Kumar Verma
2
Affiliations
1
Center for Predictive Medicine, University of Louisville, Louisville, KY 40202, USA.
2
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, San Diego, CA 92130, USA.
PMID:
37376429
PMCID:
PMC10301563
DOI:
10.3390/vaccines11061040
Abstract
The COVID-19 pandemic has triggered unparalleled global disruption [...].
Publication types
Editorial